Flunisolide
- Generic Name
- Flunisolide
- Drug Type
- Small Molecule
- Chemical Formula
- C24H31FO6
- CAS Number
- 3385-03-3
- Unique Ingredient Identifier
- 78M02AA8KF
Overview
Flunisolide (marketed as AeroBid, Nasalide, Nasarel) is a corticosteroid with anti-inflammatory actions. It is often prescribed as treatment for allergic rhinitis and its principle mechanism of action involves activation of glucocorticoid receptors.
Background
Flunisolide (marketed as AeroBid, Nasalide, Nasarel) is a corticosteroid with anti-inflammatory actions. It is often prescribed as treatment for allergic rhinitis and its principle mechanism of action involves activation of glucocorticoid receptors.
Indication
For the maintenance treatment of asthma as a prophylactic therapy.
Associated Conditions
- Allergic Rhinitis (AR)
- Asthma
Clinical Trials
FDA Approved Products
Flunisolide
Manufacturer:Ingenus Pharmaceuticals, LLC
Route:NASAL
Strength:0.25 mg in 1 mL
Approved: 2022/06/24
NDC:50742-317
Flunisolide
Manufacturer:Physicians Total Care, Inc.
Route:NASAL
Strength:0.25 mg in 1 mL
Approved: 2012/09/06
NDC:54868-4799
Flunisolide
Manufacturer:Bausch & Lomb Incorporated
Route:NASAL
Strength:0.25 mg in 1 mL
Approved: 2024/02/27
NDC:24208-344
Singapore Approved Products
NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION
Manufacturer:B. Braun Melsungen AG
Form:INJECTION, EMULSION
Strength:2.496g/1000ml
Online:Yes
Approved: 2023/03/07
Approval:SIN16734P
PHOSPHO-SODA ORAL SOLUTION
Manufacturer:Casen Recordati S.L.
Form:SOLUTION
Strength:2.71g/5 ml
Online:Yes
Approved: 2003/03/17
Approval:SIN12230P
NUTRIFLEX® OMEGA SPECIAL EMULSION FOR INFUSION
Manufacturer:B. Braun Melsungen AG
Form:INJECTION, EMULSION
Strength:2.496g/1000ml
Online:Yes
Approved: 2018/04/23
Approval:SIN15469P
NUTRIFLEX® OMEGA PLUS EMULSION FOR INFUSION
Manufacturer:B. Braun Melsungen AG
Form:INJECTION, EMULSION
Strength:1.872g/1000ml
Online:Yes
Approved: 2018/04/23
Approval:SIN15468P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath